British drugmaker GSK said it was "well positioned" to respond to any potential impact from sector-specific tariffs if they ...

British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread ...

Pfizer is raising the bar for its sweeping cost-savings drive yet again, this time cranking up the total target to $7.7 ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year ...

For 2025, Regeneron reiterated its projection for research-and-development spending in a range between $5.56 billion and $5.795 billion. The company cut the top end of its forecasted range for 2025 ...

In the fast-paced pharmaceutical industry, sales teams face increasing pressure to meet sales targets, engage healthcare professionals effectively, and stay ahead of constant product innovations. Yet, ...

Despite the wide-ranging tariffs, India’s pharmaceutical sector has escaped immediate impact. The U.S. is India’s largest pharmaceutical export market, with Indian firms supplying 45% of ...